Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.17 -0.01 (-0.85%) Market Cap: 16.63 Mil Enterprise Value: 20.30 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Q3 2019 Cumberland Pharmaceuticals Inc Earnings Call Transcript

Nov 12, 2019 / 09:30PM GMT
Release Date Price: $5.67 (-0.87%)
Operator

Thank you for joining the Cumberland Pharmaceuticals Third Quarter 2019 Financial Report and Company Update. Please note that this conference call is being recorded at the company's request and will be archived on Cumberland's website for 1 week from today's date.

Now I would like to introduce Erin Gull, who is responsible for Corporate Relations at Cumberland. Erin, please go ahead.

Erin Smith Gull
Cumberland Pharmaceuticals Inc. - Senior Corporate Relations Associate

Good afternoon, everyone. Today's call may contain forward-looking statements within the meaning of the Private Securities Reform Act of 1995. And because the statements in today's call reflect the company's current views and expectations concerning future events, any forward-looking statements may involve risks and uncertainties. And please note that many factors could affect the company's future results, as more fully described under the caption Risk Factors in our Form 10-K and any updates we file with the SEC.

Any forward-looking statements made during today's call are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot